Bioengineering’s Post

🤗 Dear connections, I've been quietly working on a groundbreaking project for years, and it's felt like striking gold. Now, I can't wait to share it with you! As I delve deeper into GPT technology, I'm continually amazed by its vast potential and complexity. 🚀 I'm excited to: - Share this journey with you 🌟 - Discover new avenues for collaboration 🤝 - Gain from your invaluable insights 💡 🤔 Curious? Your feedback and support mean the world to me. Let's connect and innovate together! 🌐✨ #Biotechnology #Healthcare #LifeSciences #Neuroscience #CognitiveHealth #Innovation #Research #Startups #Funding #Technology #Entrepreneurship #CognitiveHealth #Bioinformatics #MolecularBiology #Biotech #Microbiology #Genetics #Biochemistry #CellBiology #Laboratory #MedicalScience #instascience #lablife #sciencestudent #pharmaceuticals #microbiologylab #biotechnologist

Are you a seasoned researcher, motivated entrepreneur or industry professional passionate about bioscience and engineering? Are you like us, looking to collaborate more, contribute to and cultivate Life Sciences and Biosciences in India further? 🌱🔬 We at BioQuorum would love to talk to you, to learn more about your experiences and journey, and showcase what we have in mind. Schedule a chat with us https://lnkd.in/etSj-fmc today! _______________________________________________________ Our Motivation and Goals: A few years ago, Shruti Sridhar and I had a fantastic opportunity to found the iGEM Indian League with Priyannth RS and build a passionate team to develop Synthetic Biology in India. We spent a year working with h Ricardo Chav and the iGEM Leagues and came away with a desire to do more, across disciplines, domains and India. Our conversations with students, teachers and graduates and our own experiences at the time demonstrated a clear need. To create "future ready students" that were equipped with the right skills identified from a changing landscape. This will help them transition better from studenthood to whatever follows, whether a role in industry, academia, entrepreneurship or otherwise. To that end, we are very excited to launch BioQuorum - connecting our science journeys. A platform aimed to cultivate, collaborate and communicate bioscience and engineering. Our pilot program is "Come Do a Project with Us". A free-month long opportunity to learn about a new bioinformatics skill, apply your skill towards solving a scientific question and a chance to present your project to experts who can guide you further. In the coming weeks, we will be sharing additional information on how you can sign up and get involved. We encourage any undergraduates, from life science programs or otherwise, and highschoolers to track this space to learn more! At BioQuorum, we believe in the power of collective intelligence and the impact of collaboration in driving scientific progress. In April, we set a personal goal of reaching out to 200 (arbitrary number to get us started) life sciences experts across academia, industry and entrepreneurship in India over the next 4 months. To discuss with them areas of research, the potential of growth and to gain an appreciation of their journey so far. If you feel our vision intrigues you or anyone in your network, schedule a meeting with us using this link: https://lnkd.in/etSj-fmc and share it further. We encourage anyone who shares our vision for a more connected and collaborative scientific community to reach out and get involved. Together, we can unlock new possibilities, tackle complex challenges, and make meaningful contributions to the world of science. #india #bioscience #lifesciences #biotechnology #education #BioQuorum #ScienceCommunity #Collaboration #Innovation #Bioscience #Engineering

💡 Here's an exciting new way to explore healthcare entrepreneurship for our scientist colleagues. In the UK, Deep Science Ventures is behind the Venture Science Doctorate, a 3-year fully-funded, sector-agnostic PHD program. 🪜 This program is a new take on developing and commercializing deep tech, combining both in just 3 years: 1️⃣ Year 1 is for mapping and scoping opportunities in the industry 2️⃣ Year 2 is for hypothesis based exploration and 3️⃣ Year 3 is for venture creation And, interestingly, “all of the IP is transferred into the new venture upon completion of the program” - a bit different than typical university spinout models! ❓ This program might be a good fit for you if: ➡ You're interested and comfortable in exploring the depths of medicine (especially pharmaceuticals) but would appreciate structured guidance on the venture development side ➡ You need a bit more financial security than the typical venture-backed route and don’t mind taking a bit longer before launching your company ➡ You want to get immediately plugged in to a network of research supervisors, industry partners and venture mentors Applications for the Class of 2024 close on March 29th (link to Apply in the comments). But here are some interesting opportunities across the Deep Science Ventures ecosystem if you want to dive straight in (all roles based in the UK): Associate, New Venture Creation in Curative Therapeutics - https://lnkd.in/eAbzPhzg Co-founder in Residence, Nanoparticle Design for Neurofibromatosis Gene Therapy - https://lnkd.in/eN9b2vuW Co-Founder in Residence, Cellular Reprogramming for Curative Immune Tolerance - https://lnkd.in/ekyk2rtM Bioinformatics Consultant: Regulatory RNA Sequence Design & Structural Analysis - https://lnkd.in/en9gEVrC

🔬 From Pursuing Medicine to Embracing Biotechnology 🔬 Hello LinkedIn community! I’m excited to share my journey into biotechnology—a field that has become my passion and career focus. After aspiring to become a doctor and facing challenges in securing a government college position, I found myself exploring alternative paths. Despite hearing doubts about the scope of biotechnology in India, I followed my heart’s inclination towards this field. It was a decision driven by a deep-seated belief that I could contribute meaningfully. My interest in biotechnology stems from its promise of innovation and its potential to tackle global challenges. Particularly, I am drawn to the study of genetics and rare diseases—a niche where advancements can significantly impact lives. Today, I’m committed to leveraging biotechnology to make a positive difference. I’m eager to contribute to advancements that improve healthcare outcomes and drive scientific discovery. I look forward to connecting with like-minded professionals and experts in the field. What breakthroughs or trends do you foresee shaping the future of biotechnology? Let's collaborate and innovate towards a brighter future together! #Biotechnology #HealthcareInnovation #Genetics #RareDiseases #STEM #Science #CareerJourney #LinkedInBio

The best ways to identify new product opportunities in biotechnology 🧬 For life science vendors selling lab products and services, keep a pulse on the research market, staying in tune with what scientists need to reach their experimental goals. Don't become so focused on your own technology that you make something "cool" but that the market doesn't need. Foster relationships with key opinion leaders (KOLs) who set the trends in their particular field of research. Jennifer Doudna is a great example for CRISPR, and James Thomson is a great example for stem cells. Iterate based on their feedback until you earn the privilege to be cited in their peer-reviewed publications. Only then can you be sure that you've truly scanned the landscape to fully commercialize a new lab product or service that scientists will actually implement in their research 🔬 This is from a LinkedIn article I contributed to, which includes other tips such as... 🔹 define the problem 🔹 ideate the solution 🔹 analyze the opportunity 🔹 prioritize the options Check out the full article, and give my contribution a like: https://lnkd.in/exZaCXd2 #CRISPR #stemcells #biotechdiaries Hi, I'm Jeff Bissen (pronounced BEE-sen) 👋 I'm a life science professional with 10 years of experience - first in research, now on the business side of the industry. I also post almost every day about my perspectives on biotech. Interested? Subscribe to my Biotech Diaries newsletter: https://lnkd.in/e8r_WBP8 ***Views expressed on LinkedIn are entirely my own and not necessarily held by any past, present, or future employer***

𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $35.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 Download PDF Brochure @ https://lnkd.in/d___Qwd9 The size of global 𝐬𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐛𝐢𝐨𝐥𝐨𝐠𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $11.4 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2022 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $35.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 25.6% from 2022 to 2027 #Syntheticbiomedicineresearch has gained momentum, owing to the depleting antibiotic pipeline, rising incidence of #chronic and #debilitatingdisorders such as #cancer and #HIV; and growing need to develop effective and promising cures for several diseases that adversely affect the quality of life across the globe. The continuous rise in the funding for synthetic biology by government agencies is further supporting the growth of this market. For instance, in July , SynbiCITE, 𝐔𝐊’𝐬 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐞𝐧𝐭𝐫𝐞 for the 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐚𝐥 𝐓𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐔𝐒𝐃 5.7 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 (£5.5𝐦) 𝐟𝐮𝐧𝐝𝐢𝐧𝐠 𝐜𝐨𝐦𝐦𝐢𝐭𝐦𝐞𝐧𝐭 𝐟𝐫𝐨𝐦 𝐒𝐲𝐧𝐁𝐢𝐨𝐕𝐞𝐧. Founded , SynBioVen is a venture capital investment firm based in #UnitedKingdom. The firm focuses to invest across the healthcare and #biotechnologysectors. The funding will enable the Imperial-hosted centre to continue to support synthetic biology startups and #SMEs, strengthen the emerging UK #bioeconomy and help unlock the societal benefits of #syntheticbiology. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Bestzyme      Erisyon  5Metis, Inc.      Indian Institute of Sustainability      Lorven Biologics     iGEM KU Leuven      PhaBuilder Cancer Research Malaysia    BioPACIFIC MIP     Skretas Lab        Trobix Bio      Zvi Meitar Institute for Legal Implications of Emerging Technologies      MIT-WPU Department of Biosciences & Technology      Dreamfold   Switchback Systems      iGEM IISc Bengaluru      1Globe Health Institute      Macquarie University Applied BioSciences     UW-Madison Biomedical Engineering      New England Biolabs GmbH      UT Microbe Hackers      Jananom Private Limited      iGEM at Berkeley   BIOSS Centre for Biological Signalling Studies      iGEM Toronto    Alturki Ventures      iGEM McGill    PartitionBio Ltd      GF FERMENTECH Inc. / 지에프퍼멘텍      Cornell iGEM Project Team      McMaster SynBio      Waterloo iGEM     NSF Center for Genetically Encoded Materials      iGEM IIT Madras       Tidetron Bioworks Technology Co., Ltd. .       CompuGene Student Lab   

🌐 Biotechnology: Pioneering Progress from Past to Future 🚀🧬 On this National Biotechnology Day, let's delve into the remarkable journey of biotechnology, tracing its transformative impact from historical breakthroughs to the boundless possibilities that lie ahead. 🔍 Past Marvels: Reflect on pivotal discoveries that laid the groundwork for biotechnology, such as the advent of genetic engineering, recombinant DNA technology, and the mapping of the human genome. These milestones have shaped industries, healthcare, and agriculture. 🌱 Present Innovations: Celebrate contemporary advancements propelling biotechnology forward. Examples include CRISPR gene editing revolutionizing precision medicine, the rise of personalized therapies, and the integration of synthetic biology in sustainable solutions. 🚀 Future Frontiers: Envision the limitless potential of the future. Bioinformatics unraveling complex biological mysteries, regenerative medicine transforming healthcare landscapes, and innovative approaches to addressing global challenges exemplify the trajectory of biotechnology. 🌍 Global Collaboration: Acknowledge the power of international partnerships and shared knowledge in shaping the biotech landscape. Companies like Illumina, Novartis, and Moderna showcase how collaborative efforts transcend borders for impactful advancements. 🤝 Engage and Educate: Use this day to foster discussions about biotechnology. Share insights, dispel myths, and inspire the next generation. Education is pivotal in building understanding and embracing the potential of this dynamic field. 🔬 Everyday Biotech: Recognize biotech applications in our daily lives—vaccines by Pfizer UK and BioNTech SE , biofuels developed by companies like Amyris , and sustainable agriculture practices championed by companies such as Bayer. Biotechnology is interwoven into our existence. 🎉 Join the celebration by sharing your thoughts on the past, present, and future of biotechnology! What biotech innovations inspire you? How do you envision biotechnology shaping our future? #WorldBiotechnologyDay #BiotechInnovation #ScienceForChange #FutureOfBiotech #GlobalCollaboration Happy National Biotechnology Day! 🌐🔬

Which city is ranked #1 for Biopharma in 2024? Article in Genetic Engineering & Biotechnology News discusses the research and reveals the rankings. What did these regions do right? According to the researchers, the top three regions: 1. Invested in biotech early “At the regional level,” the commentary noted, “pioneering has a long and lasting impact. Analysis reveals that the impact of early investments in an emerging field such as biotech spans more than three decades.” 2. Generated science of outstanding quantity and quality Scientific excellence was sustained even as the industry matured. 3. Built networks with partners These networks included organizations and individuals outside of the region. Broadened their clusters beyond anchor businesses. Each region included organizations besides a single multinational giant. The 2024 rankings criteria included: Talent Pool:  The concentration of skilled professionals, supported by leading universities and research institutions, is paramount. A robust educational infrastructure ensures a continuous influx of fresh talent and innovative thinking. Research Funding:  Access to substantial public and private research funding fuels groundbreaking discoveries. Strong financial support from government grants, venture capital, and private investments propels research and development efforts. Industry Presence:  A high density of biopharma companies, ranging from startups to established giants, fosters a collaborative and competitive environment. This ecosystem promotes innovation and accelerates the commercialization of new therapies. Infrastructure:  State-of-the-art facilities, advanced laboratory spaces, and supportive regulatory environments are critical for research and production activities. These physical and regulatory infrastructures enable efficient and effective biotech operations. Collaborations and Partnerships:  Proximity to hospitals, academic institutions, and other biotech companies enhances opportunities for partnerships and collaborative research projects. These alliances are crucial for translating research into real-world medical solutions. Quality of Life:  Attractive living conditions, including affordable housing, cultural amenities, and a vibrant community, help attract and retain top talent in the region. Click below to see where your city ranked. https://lnkd.in/gBpVdfxc #biotech #rankings #biopharma #NIHfunding #innovation #venturecapital